AN ACT relating to opioid antagonists designed to reverse the effects of an opioid overdose.

SB 56 AN ACT relating to opioid antagonists designed to reverse the effects of an opioid overdose

Kentucky 2022 Regular Session

AN ACT relating to opioid antagonists designed to reverse the effects of an opioid overdose.
SB-56


About SB-56

Amend KRS 15.291, 217.177, and 217.186 to define "opioid antagonist" as naloxone or any United States Food and Drug Administration-approved opioid antagonist designed to reverse the effects of an opioid overdose; replace references to naloxone with opiod antagonist.

  

Bill Texts

Chaptered

Engrossed

Introduced

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

Sponsors (2)

Votes

House: Veto Override RCS# 491

03/30/2022

Yeas: 98 | Nays: 0
Support by Party

   

Senate: Third Reading RSN# 1961

01/19/2022

Yeas: 35 | Nays: 0
Support by Party

   

Sponsors by party

  

Bill Sponsors

History

Signed By Governor (acts Ch. 154)

04/08/2022

Signed By Governor

04/08/2022

Delivered To Governor

03/30/2022

Enrolled, Signed By President Of The Senate

03/30/2022

Enrolled, Signed By Speaker Of The House

03/30/2022

Received In Senate

03/30/2022

3rd Reading, Passed 98-0

03/30/2022

Posted For Passage In The Consent Orders Of The Day For Wednesday, March 30, 2022

03/30/2022

Returned To Rules

03/29/2022

Taken From The Orders Of The Day

03/29/2022

Posted For Passage In The Regular Orders Of The Day For Wednesday, March 23, 2022

03/22/2022

2nd Reading, To Rules

03/18/2022

Reported Favorably, 1st Reading, To Calendar

03/17/2022

To Health & Family Services (h)

03/09/2022

To Committee On Committees (h)

01/20/2022

Received In House

01/20/2022

3rd Reading, Passed 35-0 With Floor Amendment (1)

01/19/2022

Floor Amendment (1) Filed

01/18/2022

Passed Over And Retained In The Orders Of The Day

01/18/2022

Posted For Passage In The Regular Orders Of The Day For Tuesday, January 18, 2022

01/13/2022

2nd Reading, To Rules

01/13/2022

Reported Favorably, 1st Reading, To Calendar

01/12/2022

To Health & Welfare (s)

01/10/2022

Introduced In Senate

01/06/2022

To Committee On Committees (s)

01/06/2022